ALLTRNA
Live / Allowed — Published for opposition (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99446683
- Mark type
- Stylized text
- Filed
- 16 Oct 2025
- Published for opposition
- 31 Mar 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Nucleic acid for pharmaceutical purposes; oligonucleotides for therapeutic and pharmaceutical purposes
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and the development of nucleic acid based and oligonucleotide pharmaceuticals
Owner
- Alltrna, Inc., Cambridge, MA, US
- Alltrna, Inc., Cambridge, MA, US
Prosecution history
- 31 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Oct 2025 — NEW APPLICATION ENTERED